|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 22.70 SEK | -1.30% |
|
-2.78% | -60.73% |
| 08-20 | EQL Pharma AB Appoints Niraj Kumar as New Board Member | CI |
| 08-17 | EQL Pharma CFO Allan Sylvest Aasberg makes his first share purchase | FW |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.30% | -2.78% | -16.08% | -4.22% | -60.73% | -65.61% | -14.98% | -29.94% | +246.56% | 68.04M | |
| -0.11% | +0.06% | -1.37% | +9.62% | -35.14% | -45.86% | -11.33% | -52.06% | - | 14.63B | |
| +1.63% | +1.52% | -4.73% | +12.16% | -20.13% | +4.74% | -30.22% | -15.09% | +49.01% | 6.2B | |
| -0.95% | -3.03% | -9.22% | +1.85% | -27.17% | -11.47% | +4.33% | -23.84% | -9.97% | 6.1B | |
| +0.51% | -3.18% | -6.22% | +1.96% | -9.72% | -18.49% | -8.66% | +45.46% | +182.52% | 6.1B | |
| +1.42% | +1.06% | -7.28% | -6.98% | -43.27% | -56.98% | -41.29% | -74.42% | -33.99% | 5.9B | |
| +1.30% | +5.52% | +1.88% | +29.64% | +7.32% | -5.44% | -20.24% | -24.81% | +114.10% | 4.21B | |
| +0.11% | -0.05% | -1.46% | -2.04% | -4.11% | -23.45% | -36.82% | - | - | 3.15B | |
| +0.94% | -3.50% | -4.49% | +0.40% | -21.81% | -28.11% | -18.78% | -34.72% | +14.70% | 3.1B | |
| +2.08% | +1.28% | -1.36% | +21.09% | +3.29% | +10.37% | -27.63% | -38.20% | - | 3.09B | |
| -2.34% | -1.42% | +5.29% | -8.12% | -37.90% | -40.70% | -19.20% | -24.74% | +64.40% | 2.98B | |
| -0.44% | +0.97% | -5.53% | -20.79% | -32.29% | -30.03% | +25.99% | -8.16% | +36.59% | 2.89B | |
| -0.11% | -1.54% | -4.26% | -6.10% | -17.02% | -17.62% | -11.89% | +4.78% | -15.43% | 2.66B | |
| +0.15% | -5.59% | +10.11% | -2.46% | +35.73% | +55.70% | - | - | - | 2.58B | |
| +0.71% | -7.22% | -9.80% | +2.91% | -20.67% | -7.34% | +28.62% | +44.77% | - | 2.23B | |
| -0.50% | +0.50% | -8.92% | -6.59% | -24.18% | -28.44% | -14.69% | +26.67% | +95.56% | 2.22B | |
| -0.28% | -13.32% | -5.56% | +10.58% | +25.09% | +34.86% | +78.49% | -59.61% | - | 2.1B | |
| -6.08% | +11.87% | +10.34% | +4.32% | +5.68% | -6.59% | -31.88% | -46.12% | - | 1.71B | |
| -0.39% | +4.88% | +13.66% | +33.68% | +81.11% | +84.93% | +110.97% | +274.75% | +417.41% | 1.58B | |
| +1.16% | +1.09% | -0.69% | +18.98% | -11.89% | -20.44% | -33.68% | -52.91% | -38.69% | 1.48B | |
| Average | -0.12% | -1.12% | -2.28% | +4.49% | -10.39% | -10.80% | -3.84% | -4.90% | +86.37% | 3.75B | |
| Weighted average by Cap. | +0.16% | -1.46% | -2.71% | +5.05% | -16.65% | -17.89% | -9.89% | -18.31% | +60.90% |
- Stock Market
- Stocks
- EQL Stock
- Sector EQL Pharma AB
Select your edition
All financial news and data tailored to specific country editions
